Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.6
-5.88 %
$ 315 M
Market Cap
-2.39
P/E
ESPR - RETAINED EARNINGS
Retained Earnings ESPR - Esperion Therapeutics, Inc.
-1.55 B
LAST VALUE
-18.34%
2 YEAR CAGR
-20.97%
5 YEAR CAGR
-36.69%
10 YEAR CAGR